GCL
CBMG

Glazer Capital LLC’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Glazer Capital LLC’s Portfolio CBMG Stock Details CBMG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-232,103
Closed -$4.27M – 856
2020
Q4 		$4.27M Buy
232,103
+29,945
+15% +$550K 0.15% 157
2020
Q3 		$3.71M Buy
+202,158
New +$3.71M 0.18% 130